BACKGROUND: In Guillain-Barré syndrome (GBS), the diversity in electrophysiological subtypes is unexplained but may be determined by geographical factors and preceding infections. Acute motor axonal neuropathy (AMAN) is a frequent GBS variant in Japan and one study proposed that in Japan, Campylobacter jejuni infections exclusively elicit AMAN. In The Netherlands C jejuni is the predominant type of preceding infection yet AMAN is rare. This may indicate that not all Dutch GBS patients with C jejuni infections have AMAN. OBJECTIVE: To determine if GBS patients with a preceding C jejuni infection in The Netherlands exclusively have AMAN. METHODS: Retrospective analysis of preceding infections in relation to serial electrophysiology and clinical data from 123 GBS patients. C jejuni related cases were defined as having preceding diarrhoea and positive C jejuni serology. Electrophysiological characteristics in C jejuni related cases were compared with those in viral related GBS patients. In addition, eight GBS patients from another cohort with positive stool cultures for C jejuni were analysed. RESULTS: 17 (14%) of 123 patients had C jejuni related GBS. C jejuni patients had lower motor and higher sensory action potentials compared with viral related cases. Nine (53%) C jejuni patients had either AMAN or inexcitable nerves. However, three (18%) patients fulfilled the criteria for acute inflammatory demyelinating polyneuropathy (AIDP). Also, two (25%) of eight additional patients with a C jejuni positive stool sample had AIDP. CONCLUSION: In The Netherlands, C jejuni infections are strongly, but not exclusively, associated with axonal GBS. Some patients with these infections fulfil current criteria for demyelination.
BACKGROUND: In Guillain-Barré syndrome (GBS), the diversity in electrophysiological subtypes is unexplained but may be determined by geographical factors and preceding infections. Acute motor axonal neuropathy (AMAN) is a frequent GBS variant in Japan and one study proposed that in Japan, Campylobacter jejuniinfections exclusively elicit AMAN. In The Netherlands C jejuni is the predominant type of preceding infection yet AMAN is rare. This may indicate that not all Dutch GBSpatients with C jejuni infections have AMAN. OBJECTIVE: To determine if GBSpatients with a preceding C jejuni infection in The Netherlands exclusively have AMAN. METHODS: Retrospective analysis of preceding infections in relation to serial electrophysiology and clinical data from 123 GBSpatients. C jejuni related cases were defined as having preceding diarrhoea and positive C jejuni serology. Electrophysiological characteristics in C jejuni related cases were compared with those in viral related GBSpatients. In addition, eight GBSpatients from another cohort with positive stool cultures for C jejuni were analysed. RESULTS: 17 (14%) of 123 patients had C jejuni related GBS. C jejunipatients had lower motor and higher sensory action potentials compared with viral related cases. Nine (53%) C jejunipatients had either AMAN or inexcitable nerves. However, three (18%) patients fulfilled the criteria for acute inflammatory demyelinating polyneuropathy (AIDP). Also, two (25%) of eight additional patients with a C jejuni positive stool sample had AIDP. CONCLUSION: In The Netherlands, C jejuni infections are strongly, but not exclusively, associated with axonal GBS. Some patients with these infections fulfil current criteria for demyelination.
Authors: Farrah J Mateen; David R Cornblath; Hamid Jafari; Russell T Shinohara; Devendra Khandit; Bina Ahuja; Sunil Bahl; Roland W Sutter Journal: Vaccine Date: 2011-10-11 Impact factor: 3.641
Authors: L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer Journal: J Neurol Date: 2016-08-02 Impact factor: 4.849
Authors: Leora Vegosen; Meghan F Davis; Ellen Silbergeld; Patrick N Breysse; Jacqueline Agnew; Gregory Gray; Laura Beane Freeman; Freya Kamel Journal: J Occup Environ Med Date: 2012-10 Impact factor: 2.162
Authors: José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs Journal: J Neurol Date: 2016-06-17 Impact factor: 4.849
Authors: B R Jackson; J Alomía Zegarra; H López-Gatell; J Sejvar; F Arzate; S Waterman; A Sánchez Núñez; B López; J Weiss; R Quintero Cruz; D Y López Murrieta; R Luna-Gierke; K Heiman; A R Vieira; C Fitzgerald; P Kwan; M Zárate-Bermúdez; D Talkington; V R Hill; B Mahon Journal: Epidemiol Infect Date: 2013-08-07 Impact factor: 4.434